- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Scoping Review Highlights Diagnostic Value of Direct Immunofluorescence in Cutaneous Vasculitis
USA: A recent scoping review has highlighted the diagnostic utility of direct immunofluorescence (DIF) test panels in assessing cutaneous vasculitis, a group of disorders characterized by inflammation of blood vessels in the skin.
The review, published in the Journal of Cutaneous Pathology emphasizes that DIF testing plays a crucial role not only in confirming a diagnosis of vasculitis but also in classifying disease subtypes and predicting potential systemic associations.
Cutaneous vasculitis can manifest in various ways, leading to skin lesions that may mimic other dermatological conditions. Accurate diagnosis is vital, as the treatment and management of vasculitis can differ significantly from other skin disorders.
Given the immune-mediated nature of non-infectious cutaneous vasculitis, skin biopsy samples are frequently sent for DIF testing when vasculitis is suspected clinically. However, the clinical significance of DIF testing has not been thoroughly evaluated in the existing literature. To fill this knowledge gap, Julia S Lehman, Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA, and colleagues systematically assessed the peer-reviewed literature on the utility of DIF in vasculitis to help inform the development of appropriate use criteria by the American Society of Dermatopathology.
For this purpose, the researchers searched two electronic databases for articles on direct immunofluorescence (DIF) and vasculitis, covering the period from January 1975 to October 2023. They included relevant case series featuring three or more patients, published in English, and available in full text. Additional articles were identified through manual reference review. Given the heterogeneity of the studies, the findings were analyzed descriptively.
The key findings were as follows:
- Out of 255 articles identified, 61 met the inclusion criteria, collectively representing over 1,000 DIF specimens.
- Several studies estimated the sensitivity of DIF to be around 75%.
- Vascular immunoglobulin A (IgA) deposits identified by DIF were linked to renal disease, while other systemic associations varied.
- Vascular IgG deposition may be more prevalent in ANCA-associated vasculitis.
- The presence of granular vascular and epidermal basement membrane zone immunoglobulin deposition was able to differentiate between hypocomplementemic and normocomplementemic urticarial vasculitis. However, few studies have explored the added value of DIF compared to routine microscopy alone in vasculitis.
"The use of DIF testing, along with biopsy and hematoxylin and eosin staining, continues to be a cornerstone of the gold standard work-up for diagnosing vasculitis. This is particularly true for IgA vasculitis, where IgA deposits are closely linked to an increased risk of renal disease," the researchers wrote.
"Further studies are needed to compare the sensitivity of DIF testing with that of histopathology," they concluded.
Reference:
Lehman JS, Ferringer TC, Fung MA, Cassarino DS, Shalin SC. Diagnostic utility of direct immunofluorescence test panels for cutaneous vasculitis: A scoping review. J Cutan Pathol. 2024 Sep 22. doi: 10.1111/cup.14722. Epub ahead of print. PMID: 39307568.
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751